Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

Omnicell stock opened at $36.99 on Thursday. The stock has a market cap of $1.73 billion, a P/E ratio of 137.01, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The company has a ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported fourth-quarter profit of $15.8 million. On a per-share basis, the Fort Worth, Texas-based company ...

Importantly, our data indicates that Omnicell's profit was reduced by US$9.9m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits ...